http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020158757-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69e455f3dfb137aa43750dcda08c7b52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78c81eee3745be3f24f94e9de1686991
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-02
filingDate 2020-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dca98a76add22a9308f8e2251349105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de30a524ab4725b71aca66cc3add55f7
publicationDate 2020-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2020158757-A
titleOfInvention Optical isotropic liquid crystal composition and optical switching device using it
abstract PROBLEM TO BE SOLVED: To provide an element in which a liquid crystal medium exhibiting an optically isotropic liquid crystal phase, particularly a blue phase liquid crystal medium, is used for polarization control application, and a decrease in effective dielectric constant is suppressed in a high frequency region. SOLUTION: A liquid crystal composition containing an achiral component T and having a liquid crystal phase exhibiting optically isotropic properties, wherein the achiral component T is a compound represented by the formula (1) as a first component. A liquid crystal composition used for optical switching in which retardation is controlled by electric field-induced birefringence, which comprises at least one compound selected from the group and at least one compound as a second component. (R 1 is alkyl, ring A 1 is 1,4-cyclohexylene or the like; ring B 1 is 1,4-phenylene or the like; L 11 is F or the like; L 12 to L 14 is H or the like; X 1 is alkyl or the like; n 1 is 1 or 2) [Selection diagram] None
priorityDate 2019-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12443366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23678802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415806325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448661552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13759502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421187826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448867403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422032068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122632032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67537304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449171544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456060643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5326161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415777113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454436646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458418124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135534491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412235293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6731

Total number of triples: 59.